GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Taiko Pharmaceutical Co 4574.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

260

0.00%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2024

Revenue

¥6.29bn

FY2015FY2024

Net income

¥898.0m

FY2015FY2024

Free cash flow

¥175.0m

FY2015FY2024

Shareholders' equity

¥7.96bn

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue¥6.29bn¥6.12bn¥5.04bn¥11.30bn¥17.58bn¥14.97bn¥10.42bn¥9.46bn¥8.29bn¥8.33bn
Gross profit¥3.67bn¥2.58bn¥1.08bn¥3.33bn¥12.32bn¥10.61bn¥7.20bn¥6.57bn¥5.58bn¥5.77bn
Research and development¥183.0m¥245.0m¥384.0m¥546.0m¥374.8m¥449.4m¥410.4m¥317.1m¥276.1m¥358.8m
Operating income¥629.0m−¥1.00bn−¥3.08bn−¥4.95bn¥5.65bn¥3.82bn¥2.03bn¥1.86bn¥1.55bn¥1.35bn
Net income¥898.0m−¥3.61bn−¥4.89bn−¥9.59bn¥3.85bn¥2.45bn¥1.42bn¥1.09bn¥1.05bn¥840.1m
Diluted earnings per share17.89-76.25-112.27-220.5189.1857.3432.9625.6925.2721.28

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assets¥12.91bn¥13.22bn¥15.05bn¥22.54bn¥31.76bn¥25.47bn¥21.60bn¥20.47bn¥18.79bn¥16.31bn
Cash and short-term investments¥4.53bn¥5.48bn¥3.50bn¥6.10bn¥4.94bn¥9.91bn¥7.23bn¥6.55bn¥6.80bn¥3.00bn
Total liabilities¥4.95bn¥6.48bn¥7.00bn¥9.73bn¥8.98bn¥6.10bn¥4.11bn¥4.05bn¥3.40bn¥3.17bn
Debt¥2.03bn¥3.25bn¥3.81bn¥4.77bn¥94.9m¥78.0m¥55.4m¥29.1m¥33.7m¥42.0m
Shareholders' equity¥7.96bn¥6.74bn¥8.04bn¥12.81bn¥22.78bn¥19.37bn¥17.49bn¥16.42bn¥15.38bn¥13.14bn
Shares outstanding50m47m44m44m43m43m43m43m42m39m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations¥362.0m−¥307.0m−¥1.99bn−¥1.60bn−¥1.52bn¥3.49bn¥1.75bn−¥59.6m¥2.70bn¥377.7m
Capital spending−¥187.0m−¥114.0m−¥84.0m−¥1.60bn−¥2.23bn−¥220.3m−¥505.6m−¥128.6m−¥111.6m−¥3.72bn
Free cash flow¥175.0m−¥421.0m−¥2.08bn−¥3.20bn−¥3.74bn¥3.27bn¥1.24bn−¥188.2m¥2.59bn−¥3.34bn
Dividends paid−¥1.0m−¥1.0m—−¥782.0m−¥845.8m−¥499.2m−¥498.5m−¥282.7m−¥195.7m−¥319.9m

Latest quarters

By quarter end

Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
Revenue¥1.82bn¥1.26bn¥1.15bn¥1.71bn¥1.72bn¥1.48bn¥1.38bn¥1.70bn
Gross profit¥1.04bn¥642.0m¥679.0m¥951.0m¥1.04bn¥880.0m¥799.0m¥786.0m
Operating income¥278.0m¥2.0m¥44.0m−¥97.0m¥244.0m¥268.0m¥214.0m−¥561.0m
Net income¥390.0m−¥13.0m¥292.0m¥184.0m−¥50.0m¥292.0m¥472.0m−¥3.05bn
Diluted earnings per share7.76-0.265.823.67-1.005.829.41-61.16
Total assets¥11.88bn¥11.68bn¥12.16bn¥12.91bn¥13.14bn¥13.38bn¥13.00bn¥13.22bn
Cash and short-term investments¥3.79bn¥4.14bn¥4.67bn¥4.53bn¥4.77bn¥5.15bn¥5.24bn¥5.48bn
Debt¥27.0m¥119.0m¥421.0m¥803.0m¥1.02bn¥1.33bn¥1.63bn¥2.02bn
Shareholders' equity¥8.24bn¥7.95bn¥7.98bn¥7.96bn¥8.06bn¥8.07bn¥7.42bn¥6.74bn

Financial ratios

Data as of 30 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2019FY2018FY2017FY2016
Gross margin54.4%58.3%42.1%21.4%25.6%70.2%————
Operating margin7.2%10.0%-16.4%-61.1%-46.2%32.0%————
Net margin14.4%14.3%-59.0%-97.1%-89.5%21.8%————
Return on equity10.8%11.3%-53.6%-60.8%-74.9%16.9%————
Return on assets7.5%7.0%-27.3%-32.5%-42.6%12.1%————
Free cash flow yield8.5%4.0%-1.5%-15.1%0.0%6.7%————
Revenue growth1.7%2.8%21.4%-53.0%-39.4%18.4%————
Earnings growth2.8%-124.9%-26.2%-49.0%-349.1%57.0%————
Current ratio3.36x3.07x2.99x2.71x3.19x2.65x————
Debt to equity0.09x0.25x0.48x0.47x0.37x0.00x————
Equity ratio69.4%61.7%51.0%53.5%56.8%71.7%————
Interest coverage91.80x78.63x-125.63x-307.90x-824.67x20038.96x————
R&D as a share of sales—2.9%4.0%———4.0%3.4%3.3%4.3%
Buybacks as a share of market value-0.0%-0.1%-3.0%-11.9%-7.3%6.5%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-17.7%-15.9%-3.5%
Operating income—-30.3%-13.1%
Net income—-18.2%-6.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin50.3%37.0%54.8%61.2%
Operating margin-3.0%-29.2%1.8%9.8%
Net margin-21.9%-59.8%-17.8%-4.4%

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Price to earnings18.5-4.0-3.5-3.718.119.019.730.924.428.7
Price to sales2.62.33.43.24.03.12.73.63.12.9

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 29 Dec 2020.

FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Paid in the year10.0022.008.3335.005.005.005.003.333
  • 3-for-1 split · 30 Mar 2020
  • 3-for-1 split · 28 Jul 2009

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.